The Journal of Clinical Endocrinology & Metabolism · 1946 · 45 citations · 1 references
MedicineEndocrinologyGynecologyReproductive EndocrinologyReproductive MedicineReproductive PhysiologyEstrous CycleHormonal TherapyMenstrual CycleProgesterone TherapyUterine FibroidsUterine PathologyEstradiol PhysiologyEstrogen ExposureEstrogen Metabolism
IN A STUDY on experimental fibromyomas and their prevention, Lipschiitz and Inglesias (6) showed that subserous uterine fibromyomas and extragenital subserous fibromyomas in the abdominal cavity can be produced in guinea pigs subjected to prolonged treatment with estrogens. All estrogens, natural and artificial, free and esterified, were shown to be tumorigenic. Under certain conditions of treatment with estrogens a female guinea pig only rarely escaped the development of abdominal fibromyomas. Continuous action of the hormone was an essential factor. When a period of one week of injections was followed by a period of two weeks without injections no fibromyomas were produced even after a year of such treatment. On the other hand, minute quantities of free estradiol, insufficient to produce fibromyoma when given three times weekly by subcutaneous injection, proved highly active when absorbed from a subcutaneously implanted pellet. It was suggested that the tumorigenic action of estrogens in the normal organism is controlled by the sexual cycle with the alternation of high and low level phases of blood estrogen and by inactivation or elimination of the hormone.
1